Author: Foster R.H. Plosker G.L.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.16, Iss.1, 1999-07, pp. : 99-114
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Acamprosate: Pharmacoeconomic Implications of Therapy
PharmacoEconomics, Vol. 16, Iss. 6, 1999-12 ,pp. :
Fosphenytoin: Pharmacoeconomic Implications of Therapy
By Holliday S.M. Benfield P. Plosker G.L.
PharmacoEconomics, Vol. 14, Iss. 6, 1998-12 ,pp. :
Diclofenac/Misoprostol: Pharmacoeconomic Implications of Therapy
PharmacoEconomics, Vol. 16, Iss. 1, 1999-07 ,pp. :
Pharmacoeconomic considerations with statin therapy
By Speidel Katie M Hilleman Daniel E
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 10, 2006-07 ,pp. :
Pharmacoeconomic Implications of New Therapies in Sepsis
By Kelly A. Wood Derek C. Angus
PharmacoEconomics, Vol. 22, Iss. 14, 2004-01 ,pp. :